retatrutide type 2 diabetes phase 2 trial for Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with diabetes: a randomised, double-blind, placebo and retatrutide phase 2 trial results
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20























